Welcure Drugs Board Meeting on 29th May'26 for Q4 and FY26 Results
Welcure Drugs & Pharmaceuticals Ltd 路 Intimation 路 29 May 2026, 5:30 am
Welcure Drugs Board Meeting on 29th May'26 for Q4 and FY26 Results Welcure Drugs & Pharmaceuticals has scheduled a Board of Directors meeting on 29th May'26. The agenda includes the consideration and approval of the audited financial results for the quarter and fiscal year ended 31st Mar'26. The board will also review and approve the audited financial statements, including the Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement for the year. The statutory auditors' report on the financial results will also be taken on record.
Original exchange filing (PDF)
More announcements from Welcure Drugs & Pharmaceuticals Ltd
- Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements 路 02 Nov 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026. 路 14 Jul 2026
- Resignation of Company Secretary and Compliance Officer 路 19 Jun 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday, 19th June, 2026 路 19 Jun 2026
- Audited Standalone Financial Results for the Quarter and Year Ended 31st March, 2026 路 30 May 2026
- Outcome of the Meeting of Board of Directors of the Company held on today i.e. Friday, 29th May, 2026 路 30 May 2026
- <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... 路 23 Apr 2026
- Unaudited Financials Results for the 3rd Quarter ended on 31st December, 2025 路 13 Feb 2026
